$367.62 USD (0.00% in 24 hours)
Biopharmaceutical company focused on novel therapeutics for metabolic dysfunction-associated steatohepatitis.
As of 2026-11-04 17:30 UTC. The Crypto App market data.
Biopharmaceutical company focused on novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH).